Our best-in-class, dedicated manufacturing and R&D capabilities are poised to meet today’s customer needs, and we are committed to providing our customers and partners with high-quality specialty medicines.

After successful presence in the US and European market, we launched eugia Australia in 2024 with the aim of providing high-quality generic injetables at competitive pricing & ensuring consistent supply to the Australian market. We have already secured multiple approvals from TGA and we are optimistic about the future, with an exciting pipeline of new products. The company is dedicated to expanding its portfolio of high-quality generic medications and is working tirelessly to bring new, effective, and affordable treatments to patients, ensuring they have access to the best possible care.